Skip to main content
Clinical Trials/JPRN-UMIN000002463
JPRN-UMIN000002463
Recruiting
未知

A exploratory study of the efficacy and safety of oxaliplatin in combination with S-1 in the treatment of non-resectable gastric cancer - Oxaliplatin and S-1 therapy for gastric cancer

niversity of Tokyo Hospital0 sites20 target enrollmentSeptember 7, 2009

Overview

Phase
未知
Intervention
Not specified
Conditions
non-resectable gastric cancer or reccurent gastric cancer
Sponsor
niversity of Tokyo Hospital
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 7, 2009
End Date
March 1, 2012
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Tokyo Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • history of use of oxaliplatin severe dysfuntion of major organs Hematopoietic disorder sensory neuropathy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
An exploratory study of the efficacy and safety of yokukansan for postoperative delirium in patients who underwent surgical resection of malignant tumor of digestive system.Digestive system cancer
JPRN-UMIN000013235Hitachi,Ltd.,Hitachi General Hospital40
Recruiting
Not Applicable
An exploratory study on the efficacy and safety of Hangesyasinto (TJ-14) for DCF chemotherapy or DCF-RT chemoradiotherapy induced diarrhea in the patients with advanced esophageal cancer.
JPRN-UMIN000023825Dokkyo Medical University24
Recruiting
Phase 2
An exploratory study of the safety and efficacy of disulfiram in progressive fibrosing interstitial lung diseaseprogressive fibrosing interstitial lung diseaseinterstitial lung diseaseD017563
JPRN-jRCTs031220648rushiyama Hirokazu10
Not yet recruiting
Not Applicable
Study on the safety and efficacy of upper extremity motor function recovery after neuromodulatory stimulation using low-intensity focused ultrasound (NS-US200) in patients with ischemic strokeDiseases of the circulatory system
KCT0008320Korea University Anam Hospital12
Active, not recruiting
Not Applicable
An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe DiseasePompe disease (acid alpha-glucosidase deficiency)MedDRA version: 17.1Level: LLTClassification code 10036143Term: Pompe's diseaseSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2015-000584-14-Outside-EU/EEAGenzyme Corporation Inc4